The first commercial TIL therapy is brewing at Iovance, along with various clinical readouts which are set to come to fruition in 2023, along with the 5th TIL Therapies Summit...

Be at the forefront of the Bispecific space as it goes head to head with cell therapy to transform oncology. Among numerous innovations in cancer immunotherapy, Bispecific...